Company Filing History:
11 out of 560 
8 out of 48 Years Active: 2015-2024
Title: Innovations and Contributions of Inventor Tao Dao
Introduction
Tao Dao is a prominent inventor based in New York, NY, known for his significant contributions to the field of cancer research. With a total of 11 patents to his name, he has made remarkable strides in developing innovative therapies aimed at treating various cancers.
Latest Patents
Among his latest patents is the invention titled "Immunogenic WT-1 peptides and methods of use thereof." This invention provides peptides, immunogenic compositions, and vaccines, along with methods for treating and inducing immune responses to WT1-expressing cancers. Another notable patent is for "T cell receptor-like antibodies specific for Foxp3-derived peptides." This invention offers antigen-binding proteins, such as chimeric antigen receptors and antibodies, that target Foxp3 peptide/MHC molecule complexes. These innovations are crucial for inhibiting regulatory T cells and advancing cancer treatment.
Career Highlights
Tao Dao has worked with esteemed organizations, including Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. His work in these institutions has allowed him to focus on groundbreaking research and development in cancer immunotherapy.
Collaborations
Throughout his career, Tao Dao has collaborated with notable professionals in the field, including David A. Scheinberg and Cheng Liu. These partnerships have further enhanced his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Tao Dao's innovative work and patents reflect his dedication to improving cancer therapies. His contributions continue to influence the field and offer hope for better treatment options for patients.